Vermillion has appointed director Bruce Huebner as its interim CEO. Huebner succeeds former CEO Gail Page, who will be strategic advisor to the company and continue to serve on the board of directors.
Previously, Vermillion's board formed a committee of independent directors and charged them with selecting a new CEO for the firm. Vermillion has also engaged an executive search agency to look potential candidates.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
